You are viewing the site in preview mode

Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Clinical characteristics, organ failure, inflammatory markers and prediction of mortality in patients with community acquired bloodstream infection

BMC Infectious Diseases201818:535

https://doi.org/10.1186/s12879-018-3448-3

  • Received: 26 January 2018
  • Accepted: 16 October 2018
  • Published:
Open Peer Review reports

Abstract

Background

Community acquired bloodstream infection (CABSI) in low- and middle income countries is associated with a high mortality. This study describes the clinical manifestations, laboratory findings and correlation of SOFA and qSOFA with mortality in patients with CABSI in northern Vietnam.

Methods

This was a retrospective study of 393 patients with at least one positive blood culture with not more than one bacterium taken within 48 h of hospitalisation. Clinical characteristic and laboratory results from the first 24 h in hospital were collected. SOFA and qSOFA scores were calculated and their validity in this setting was evaluated.

Results

Among 393 patients with bacterial CABSI, approximately 80% (307/393) of patients had dysfunction of one or more organ on admission to the study hospital with the most common being that of coagulation (57.1% or 226/393). SOFA performed well in prediction of mortality in those patients initially admitted to the critical care unit (AUC 0.858, 95%CI 0.793–0.922) but poor in those admitted to medical wards (AUC 0.667, 95%CI 0.577–0.758). In contrast qSOFA had poor predictive validity in both settings (AUC 0.692, 95%CI 0.605–0.780 and AUC 0.527, 95%CI 0.424–0.630, respectively). The overall case fatality rate was 28%. HIV infection (HR = 3.145, p = 0.001), neutropenia (HR = 2.442, p = 0.002), SOFA score 1-point increment (HR = 1.19, p < 0.001) and infection with Enterobacteriaceae (HR = 1.722, p = 0.037) were independent risk factors for in-hospital mortality.

Conclusions

Organ dysfunction was common among Vietnamese patients with CABSI and associated with high case fatality. SOFA and qSOFA both need to be further validated in this setting.

Keywords

  • Bloodstream infection
  • Organ failure
  • Sequential organ failure assessment score
  • SOFA
  • qSOFA
  • Inflammatory markers
  • Procalcitonin
  • C-reactive protein

Background

Bloodstream infection (BSI) is a common cause of sepsis and is associated with significant morbidity and in-hospital mortality worldwide [1]. It is ranked the 11th leading cause of death among adults in USA in 2014, with an age-adjusted death rate of 10.7 per 100,000 standard population [2]. In South and Southeast Asia, the incidence rate of community-acquired BSI in the period of 2004–2010 increased from 16.7 to 38.1 per 100,000 people per year and the 30 days mortality rate can reach up to 37.5% [3].

In patients with BSI, an increasing number of organs with dysfunction is correlated with increased morbidity and mortality [4]. Multiple organ dysfunction is a leading cause of morbidity and mortality in patients admitted to intensive care units (ICUs) in Europe, with an in-hospital mortality of 34.2% [5]. Sequential organ failure assessment (SOFA) score, and the related qSOFA (quickSOFA) score have been recently recommended for identifying sepsis and predicting outcome by the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [6]. qSOFA was originally designed for use outside the ICU, but it’s simplicity, brevity and lack of laboratory results, make it compelling for use in emergency departments and resource-constrained setting. However the validation of qSOFA is not consistent among studies quantifying the risk of death in those presenting with suspected infection in critical care [69]. Development and validation of these scores were mostly carried out in high income countries, with limited data on their validity in low- and middle income countries (LMICs) [7, 8, 10]. Additionally there have been few studies looking specifically at patients with BSI, a population with an associated increase in mortality.

This study aims to describe the clinical manifestations and associated organ dysfunctions as described by Sequential [Sepsis-related] Organ Failure Assessment (SOFA) scores and its correlation with mortality in patients with community acquired bloodstream infection at the time of presenting to a large teaching hospital in Vietnam, and their associated mortality.

Methods

Study design

This was a retrospective, cohort study of patients hospitalised at the National Hospital for Tropical Diseases (NHTD) (a tertiary referral infectious disease hospital) in northern Vietnam between January 2011 and December 2013. As a referral centre, this hospital often receives patients with specific infections (eg. central nervous system infections), complicated infections and those with severe infections who have failed on treatment elsewhere. Additionally, at the time of the study, the hospital had not establish a separate emergency department and intensive care unit (ICU), therefore we refer to the critical care unit (CCU) for the unit with both ventilated and unventilated beds, available haemodynamic support and renal replacement therapy. A convenience sampling method was used to select medical notes from the list of all hospitalised patients with positive bacterial blood cultures during the study period. The inclusion criteria were having a blood culture, taken within 48 h of hospitalisation (to any institution) for the current admission, positive for a recognised pathogen according to the US CDC’s National Healthcare Safety Network (NHSN) list [11]. Patients with infection with more than one bacterium were excluded, as were cases considered to be pseudobacteraemia [12].

Data collection

Data was extracted from patients’ medical notes using a case-report form that captured patient demographics, reported history of prior medical illness, clinical manifestations, laboratory results, inflammatory markers within the first 24 h of admission to the study hospital and outcome at hospital discharge.

BSI with concurrent meningitis was defined in bacteremic patients who had cerebrospinal fluid examination within 24 h of blood drawn for microorganism isolation showing at least one of the following criteria: (1) turbid appearance; (2) leukocytosis (> 100 cells/mm3) or (3) leukocytosis from 10 to 100 cells/ mm3) and either an elevated protein (> 100 mg/dl) or decreased glucose (< 40 mg/dl) [13]. BSI with concurrent pneumonia was confirmed by radiology within 24 h of blood drawn for microorganism isolation. Gastrointestinal tract infection and urine tract infection were defined by the CDC/NHSN Surveillance Definitions for Specific Types of Infections [14]. Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score, and quick SOFA (qSOFA) score were calculated using the worst parameters recorded within the first 24 h of admission to the study hospital and missing values were considered to be normal [6]. Organ dysfunction was defined by organ-specific SOFA scores ≥1. Failure of kidney function was further evaluated using the RIFLE criteria with RIFLE-F (Failure) defined as patients with a serum creatinine greater than three times the age adjusted upper limit of serum creatinine [15]. Neutropenia was defined as an absolute neutrophil count < 1500 cells/mm3, severe anemia as hemoglobin concentration was < 80 g/L and thrombocytopenia as a platelet count below 100 × 103 cells/mm3.

The outcome at hospital discharge was defined as death for those who died in hospital or were palliatively discharged (discharged home for palliative care with the expectation of an early death, as per common practice in Vietnam) and ‘survived’ in all other cases.

Data analysis

Data was analysed using IBM SPSS Statistics for Windows (IBM Corp., Armonk, NY). Depending on the distribution, continuous data were presented as mean (95% confidence interval) or median (interquartile range) and categorical data as number (percentage). To evaluate the predictive value of SOFA, qSOFA score, white blood cell counts, C-Reactive Protein (CRP) and procalcitonin levels, a receiver operating characteristic (ROC) curve and the area under the curve (AUC) were calculated along with the sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios associated with the cut-off value that gave the highest difference between sensitivity and (1-specificity) (Youden index). Since procalcitonin level was obtained by a semi-quantitative test that was only quantitatively measured for levels under 100 ng/mL, the result of “above 100 ng/mL” was considered as 100 ng/mL. The Mann Whitney U test and Kruskal Wallis test were used to analyze continuous variables and the Chi-square and Fisher’s exact were used for bivariate analyses as appropriated. Logistic regression models were used to calculate unadjusted odds ratios (ORs) and 95% confidence intervals (CIs) for associations between clinical, laboratory characteristics and case fatality rate. Comparison of AUC between different ROC curves was performed using a nonparametric approach [16]. Cox proportional hazards regression was used to identify variables that predicted clinical outcomes. Variables for inclusion were selected by review of the literature (age, HIV infection status, neutropenia, SOFA score and aetiology of CABSI). All tests were two-tailed and differences were considered statistically significant at p values ≤0.05.

Results

Among 400 patients with community acquired bloodstream infections (CABSI) there were 393 patients with infection with one bacterium included in this analysis, 7 dual infection cases were excluded (including 3 HIV infected cases with co-infection of T. marneffei and S. aureus, Escherichia hermannii or Salmonella group D; 1 case with S. aureus and K. pneumoniae, 1 case with Enterococcus faecalis and viridans streptococci, 1 case with E. coli and K. pneumoniae and 1 case with S. aureus and E. coli co-infection). Gram-negative bacteria dominated (70.7%, 278/393), comprising Enterobacteriaceae (50.9%, 200/393) and non-Enterobacteriaceae Gram-negative bacteria (19.8%, 78/393) followed by Gram-positive bacteria 29.3% (115/393).

Clinical characteristics, aetiology of CABSI and organ failure

The median age of patients included was 48 years (IQR 36–60), with 271 males and a male to female ratio of 2.2:1. There was a history of chronic disease in 27% of patients, with the highest prevalence in patients with Enterobacteriaceae BSI, 34% (38/200). Thirty-eight percent (150/393) of patients were transferred from another hospital (< 48 h) for the current illness episode. The median time from onset of illness to hospitalisation at the study site was 5 days and 36.9% (145/393) were admitted directly to critical care.

Concurrent meningitis was confirmed in 18.3% (72/393) and pneumonia in 24.9% (98/393) of patients, with both conditions occurring in 2.8% (11/393) of patients with CABSI. Gram-positive organisms were isolated from 72.2% (52/72) of those with meningitis, Enterobacteriaceae in 18.1% (13/72) and non-Enterobacteriaceae Gram-negative bacteria in 9.7% (7/72), see Table 1 for details. Concurrent meningitis was found in 6.5% (13/200) patients with Enterobacteriaceae BSI, 9.0% (7/71) patients with non-Enterobacteriaceae Gram-negative bacteria BSI and 45.2% (52/115) patients with gram positive BSI. In the 98 cases of pneumonia the causative pathogens isolated from blood were Enterobacteriaceae (46.9%, 46/98), non-Enterobacteriaceae Gram-negative bacteria (25.5%, 25/98) and Gram-positive bacteria (27.6%, 27/98) (see Additional file 1: Table S1).
Table 1

Clinical characteristic on admission of patients with bloodstream infection

Factor

Proportion

Case fatality rate

Unadjusted odds ratios (95%CI) for case fatality

P values

Age (yrs)

  ≤ 40 years old

122/393 (31%)

27 (22.1%)

1

 

 41–55 years old

152/393 (38.7%)

46 (30.3%)

1.527 (0.881–2.646)

0.131

  ≥ 56 years old

119/393 (30.3%)

37 (31.1%)_

1.588 (0.891–2.828)

0.117

Male sex (%)

271/393 (69.0%)

84 (31.0%)

1.659 (1.002–2.746)

0.049

Any previous hospitalisation (%)

150/393 (38.2%)

62 (41.3%)

2.862 (1.819–4.503)

< 0.001

Any antibiotic prior to NHTD hospitalisation (%)

50/150 (33.3%)

23 (46.0%)

1.332 (0.671–2.646)

0.412

Time from onset to current hospitalisation < 5 days

217/393 (55.2%)

57 (26.3%)

0.827 (0.532–1.286)

0.399

Direct ICU admission

145/393 (36.9%)

68 (46.9%)

4.331 (2.720–6.898)

< 0.001

Any history of medical disease

106/393 (27.0%)

44 (41.5%)

2.376 (1.479–3.818)

< 0.001

 HIV

19/393 (4.8%)

10 (52.6%)

3.044 (1.202–7.710)

0.019

 Moderate or severe liver disease

53/393 (13.5%)

25 (47.2%)

2.679 (1.481–4.844)

0.001

 Diabetes

25/393 (6.4%)

7 (28.0%)

1.001 (0.406–2.466)

0.999

Concurrent foci of infection

 Radiology-confirmed pneumonia on admission

98/393 (24.9%)a

29 (29.6%)

1.11 (0.671–1.837)

0.684

 Lumbar puncture confirmed meningitis on admission

72/393 (18.3%)b

19 (26.4%)

0.906 (0.509–1.614)

0.738

 Heart valve vegetations during hospitalisation

16/393 (4.1%)

4 (25.0%)

0.852 (0.269–2.701)

0.786

 Any abscess during hospitalisation

33/393 (8.4%)c

6 (18.2%)

0.547 (0.219–1.364)

0.196

Organ dysfunction on admission

 Cardiovascular

65/393 (16.5%)

52 (80.0%)

18.621 (9.522–36.415)

< 0.001

 Respiratory

87/393 (22.1%)

53 (60.9%)

6.81 (4.057–11.431)

< 0.001

 CNS

105/393 (26.7%)

55 (52.4%)

4.66 (2.876–7.551)

< 0.001

 Hepatic

146/393 (37.2%)

57 (39.0%)

2.344 (1.494–3.678)

< 0.001

 Renal

153/393 (38.9%)

66 (43.1%)

3.379 (2.139–5.339)

< 0.001

 Coagulation

226/393 (57.5%)

85 (37.6%)

3.424 (2.070–5.663)

< 0.001

aIsolates from blood in patients with pneumonia were K. pneumoniae (22.4%, 22/98), E. coli (16.3%, 16/98), S. maltophilia (11.2%, 11/98), Burkholderia pseudomallei (8.2%, 8/98), S. aureus (7.1%, 7/98) and S. suis (7.1%, 7/98) and other pathogens (23.5%, 27/98)

bIsolates from blood in patients with meningitis were S. suis (40/72, 55.6%), K. pneumoniae (8/72, 11.1%), Stenotrophomonas maltophilia (7/72, 9.7%), S. aureus (5/72, 6.9%). Enterococcus species (2/72, 2.8%), Listeria species (2/72, 2.8%), E. coli (2/72, 2,8%), Salmonella enterica (2/72,2.8%) and each of S. pneumoniae, beta hemolytic Streptococcus, viridans group Streptococcus and Enterobacter species (1/72, 1.4%)

cThere were 16 cases with liver abscess with isolates from blood were K. pneumoniae (8/16 or 50%), E. coli and Salmonella enterica (2/16 of each, or 12.5%), Aeromonas species, Enterobacter species, S. suis and viridans group streptococci (1/16 of each, 6.3%)

A further 8.4% (33/393) of patients presented with or developed at least one abscess, of which 2 patients (6.1%) had 2 abscess foci and 1 patient (3.0%) had 3 abscess foci in different locations. The locations were 16/37 (43.2%) liver, 8 (21%) skin, 4 (10.8%) muscle, 3 (8.1%) brain, 3 (8.1%) spleen, 2 (5.4%) lung, 1 (2.7%) eyelid. Endocarditis was confirmed by echocardiography in 4.1% (16/393) patients. These were due to Staphylococcus aureus (7/16, 43.8%), viridans group streptococci (4/16, 28.6%), Enterococcus species (3/16, 18.8%), Klebsiella pneumoniae (1/16, 6.25%) and Pseudomonas aeruginosa (1/16, 6.25%). The distribution of aetiology by the foci of infection is presented in Additional file 1: Table S1.

On the day of admission to the study hospital, BSI patients had a median SOFA score of 3 (IQR 1–7) and 78.1% (307/393) of patients had dysfunction of at least one organ. The SOFA score differed significantly between patients admitted direct to CCU (median of 7, IQR 4–12) and medical wards (median of 2, IQR 0–4) (p < 0.001). Enterobacteriaceae BSIs accounted for most cases with SOFA score above 12 (74% or 28/38, vs. 48% (172/355) in patients with SOFA score ≤ 12, p = 0.003) or more than 3 organ dysfunctions (60% or 47/78, vs. 49% or 153/315 in patients with ≤3 organ dysfunctions, p = 0.065). qSOFA score was ≥2 in 28.6% (71/248) of patients that were initially admitted to medical wards. The unadjusted associations between clinical factors and case fatality are presented in Table 1.

Laboratory results and inflammatory markers

The proportions of patients with white blood cells count < 4 × 109/l, 4–12 × 109/l and > 12 × 109/l were 11.8% (46/389), 47% (183/389) and 41.1% (160/389) respectively. Neutropenia, severe anaemia and thrombocytopenia was presented in 7.2% (28/388), 8% (31/389) and 43.4% (169/389) patients with BSI on admission to the study hospital, respectively. The proportion of patients with RIFLE-F, increased lactate, procalcitonin or CRP were not significantly different when classified by bacterial aetiology (Enterobacteriaceae, non-Enterobacteriaceae and Gram-positive). Lactate levels were only available for 73 patients and 52/73 (69.9%) patients had lactate level ≥ 2 mmol/L on admission. The median lactate level increased significantly with increasing SOFA score; from 1.23 mmol/L (IQR: 0.99–2.04 mmol/L) in those with a SOFA score < 6, to 7.89 mmol/L (IQR: 3.7–10.38) in those with a SOFA score > 12 (p < 0.001, Kruskal Wallis test). There was no significant difference between median lactate levels in those with qSOFA < 2 and qSOFA≥2 (p = 0.055, Mann-Whitney U test). Laboratory factors associated with case mortality was showed in Table 2. There was no unadjusted associated between procalcitonin and CRP levels with case fatality rates.
Table 2

Laboratory characteristics on admission

 

Proportion

Case fatality

Unadjusted odds ratios (95%CI) for case fatality

P values

Neutropenia (< 1500 cell/mm3) (%)

28/388 (7.2%)

22 (78.6%)

11.682 (4.588–29.746)

< 0.001

Hemoglobin< 80 g/L

31/389 (8.0%)

11 (35.5%)

1.459 (0.675–3.156)

0.337

RIFLE criteria

 No renal dysfunction

283/386 (73.3%)

56 (19.8%)

1

 

 RIFLE-risk

50/386 (13.0%)

16 (32.0%)

1.908 (0.984–3.699)

0.056

 RIFLE-failure

52/386 (13.5%)

35 (67.3%)

8.346 (4.361–15.971)

< 0.001

Hypoalbuminemia (albumin ≤30 g/L)

72/245 (29.4%)

39 (54.2%)

3.263 (1.839–5.789)

< 0.001

Aspartate Aminotransferase (AST) ≥ 2 ULN

153/379 (40.4%)

65 (42.5%)

3.435 (2.150–5.487)

< 0.001

Alanine aminotransferase (ALT) ≥ 2 ULN

109/378 (28.8%)

45 (41.3%)

2.449 (1.520–3.947)

< 0.001

Platelet < 100 × 103/mm3

169/389 (43.4%)

70 (41.4%)

3.282 (2.068–5.208)

< 0.001

Procalcitonin

 PCT ≤ 0.005 ng/mL (%)

6/239 (2.5%)

2 (33.3%)

1

 

 PCT > 0.005–2 ng/mL (%)

83/239 (34.7%)

11 (13.3%)

0.306 (0.050–1.871)

0.2

 PCT > 2–10 ng/mL (%)

59/239 (24.7%)

20 (33.9%)

1.026 (0.173–6.087)

0.978

 PCT > 10–100 ng/mL (%)

69/239 (28.9%)

29 (42.0%)

1.45 (0.249–8.457)

0.68

 PCT > 100 ng/mL (%)

22/239 (9.2%)

14 (63.6%)

3.5 (0.520–23.559)

0.198

C-reactive protein (CRP) (median, IQR) (mg/L)

 CRP less than 5 mg/L (%)

14/341 (4.1%)

4 (28.6%)

1

 

 CRP from 5.01 to 20 mg/L (%)

26/341 (7.6%)

4 (15.4%)

0.455 (0.094–2.195)

0.326

 CRP from 20.001 to 100 mg/L (%)

112/341 (32.8%)

29 (25.9%)

0.873 (0.254–3.001)

0.83

 CRP more than 100 mg/L (%)

189/341 (55.4%)

56 (29.6%)

1.053 (0.317–3.498)

0.933

ULN upper limit of normal; RIFLE Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease

Mortality and associated factors

The overall case-fatality of CABSI was 28% (110/393), of which 71.8% (79/110) occurred within 7 days of admission to the study hospital. Case fatality rates in patients with CABSI due to Enterobacteriaceae, non-Enterobacteriaceae Gram-negative bacteria and Gram-positive bacteria were 33.5%, 25.6% and 20%, respectively. Among the most common isolates, the case fatality was 35.2% (31/88) in K. pneumoniae, 32.8% (21/64) in Escherichia coli, 9.3% (4/43) in Streptococcus suis, 15.4% (6/39) in Stenotrophomonas maltophilia and 32.4% (11/34) in S. aureus. The case-fatality in patients directly admitted to CCU was 46.9% (68/145).

Organ dysfunction was associated with higher risk of in-hospital mortality (33.2% patients with at least one organ dysfunction on admission to the study hospital vs 9.3% patients without, p < 0.001). Case fatality rate increased with increasing SOFA score (Fig. 1). The mortality in patients with 1, 2, 3 and more than 4 organs dysfunction was 17% (17/100), 19.5% (16/82), 31.9% (15/47) and 69.2% (54/78), respectively. The highest case fatality rates were observed in patients with cardiovascular, respiratory and central nervous system (CNS) dysfunction, 80% (52/65), 60.9% (53/87), 52.4% (55/105), respectively. qSOFA < 2 was associated with lower mortality compared with qSOFA ≥2, 18.8% (26/138) vs 40.6% (63/155), p < 0.001. Among patients admitted directly to CCU, SOFA performed well at predicting in-hospital mortality (AUC 0.858, 95%CI 0.793–0.922) while qSOFA was a poor predictor (AUC 0.692, 95%CI 0.605–0.780) in this population. However, outside of CCU, regardless of eventual CCU admission, both SOFA and qSOFA had poor predictive validity (AUC 0.667, 95%CI 0.577–0.758 and AUC 0.527, 95%CI 0.424–0.630, respectively).
Fig. 1
Fig. 1

Case fatality rate by the SOFA and qSOFA scores within the first 24 h of admission

Table 3 shows the prognostic validity of the Youden index of SOFA, qSOFA, WBC, CRP and PCT on admission to NHTD in all patients. The SOFA score was more accurate than qSOFA in predicting mortality (AUC = 0.795 vs 0.658, p < 0.001); PCT (AUC = 0.703), and WBC (AUC = 0.642) was more accurate than CRP (AUC = 0.561) in predicting mortality (P < 0.001 and P = 0.0498 respectively).
Table 3

Performance of initial SOFA score, qSOFA score, white blood cells, C-reactive protein and procalcitonin, in prediction of in-hospital mortality

 

SOFA

(n = 393)

qSOFA

(n = 393)

WBC

(n = 389)

CRP

(n = 341)

Procalcitonin

(n = 239)

AUC (95% CI)

0.795

(0.741–0.850)

0.658

(0.595–0.721)

0.642

(0.576–0.708)

0.561

(0.492–0.630)

0.703

(0.629–0.776)

Cut-off value

≥ 9

≥ 3

≤ 7.39

≥ 210

≥ 5.49

Sensitivity

53.6%

30.9%

77.9%

35.5%

69.7%

Specificity

94.7%

96.1%

49.5%

75.8%

63.2%

Positive predictive value

79.7%

75.6%

79.9%

35.5%

46.9%

Negative predictive value

84.0%

78.2%

46.6%

75.8%

81.8%

Positive likelihood ratio

10.1194

7.9521

1.5430

1.4667

1.8945

Negative likelihood ratio

0.4896

0.7189

0.4470

0.8511

0.4789

SOFA Sequential Organ Failure Assessment, qSOFA quick Sequential Organ Failure Assessment, WBC white blood cell, CRP C-reactive protein

In unadjusted association analysis, higher mortality was associated with male sex, any previous hospitalisation, direct CCU admission, history of HIV infection, moderate severe liver diseases and. Analysis, male sex, previous hospitalisation prior to NHTD admission, any history of chronic disease, history of moderate or severe liver diseases, HIV infection, organ dysfunctions on admission, neutropenia, haemoglobin < 80 g/L, RIFLE failure (RIFLE-F), hypoalbuminemia (< 30 g/L), elevated liver enzymes (> 2 times the upper limit of normal), thrombocytopenia (< 100 × 103/mm3) and were associated with increased in-hospital mortality (p values < 0.05). In Cox regression proportional hazards model, HIV infection (HR = 3.145, p = 0.001), neutropenia (HR = 2.442, p = 0.002), SOFA score 1-point increment (HR = 1.19, p < 0.001) and infection with Enterobacteriaceae (HR = 1.722, p = 0.037) were significant risk factors for in-hospital mortality (Table 4).
Table 4

Cox proportional hazards model of factors associated with all-cause in-hospital case fatality

Variable

Hazard ratio (95% CI)

P-value

Age (each increase of 1 year)

1.006 (0.994–1.019)

0.321

HIV infection

3.145 (1.569–6.305)

0.001

Absolute neutrophil count < 1500 cells/mm3

2.442 (1.381–4.319)

0.002

SOFA score (each increase of 1 point)

1.190 (1.146–1.235)

< 0.001

Aetiology of CABSI (gram-positive bacterial infection as reference)

Enterobacteriaceae infections

1.722 (1.034–2.869)

0.037

 Non Enterobacteriaceae Gram-negative infections

1.528 (0.824–2.834)

0.178

Discussion

This retrospective study describes the clinical characteristics and outcomes in this high-risk group of patients with community acquired BSI. Multi-organ dysfunction and case-fatality rates were high in all aetiological bacterial groups. SOFA score on CCU admission had good prognostic accuracy for in-hospital mortality whilst qSOFA, WBC, CRP and PCT did not.

BSI patients admitted directly to CCU in our study had a median SOFA score of 7 (IQR 4–12), comparable with large-scale validation studies of Sepsis-3 criteria in the US (median of 6, IQR 3–9) [10] and Australia and New Zealand (median of 5, IQR 3–8) [7]. The proportion of bacteraemic patients with qSOFA of 2 or above in our study (39.4%) was also higher than in studies of sepsis conducted in high income countries (10–27%) [8, 10]. The percentage of patients with pneumonia in our CABSI cohort (24.9%) was lower than or similar to other studies on CABSI (24–38%) [1719]. K. pneumoniae was the most common pathogen isolated from bacteremic patients with pneumonia in our study, reflecting its role here as an important cause of community acquired pneumonia [20]. We also confirmed the role of S. suis as the leading pathogen causing BSI associated with meningitis in Viet Nam [21]. Our findings further confirmed the reduction of Neisseria meningitidis in Viet Nam which was reported in 0.5% of blood isolates [22] and around 4.4% of cerebral spinal fluid (CSF) isolates before 2005 [23]. We also report the high prevalence of Enterobacteriacaea (18.1% or 13/72) as a cause of meningitis in adult BSI patients compared to previous studies from Viet Nam (13.5% or 30/222 of CSF isolates from 1996 and 2005) [23], Iceland (11.3% or 12/106 of positive CSF cultures during 1995–2010) [24] and Denmark (6.1% or 88/1437 during 1991–2000) [25]. The high prevalence of meningitis associated with Enterobacteriaceae in this setting may be related to Strongyloides hyperinfection, given the evidence for high seroprevalence of Strongyloides infection in this population [26].

A review of CABSI in south and Southeast Asia from 1990 to 2010 showed the most frequent isolates in adult patients were Salmonella enterica (37.8%), S. aureus (12.6%) and E. coli (12%) with an overall case fatality rate of 9% [27]. In North America and Europe, there was a significant increase in bloodstream infection caused by Gram-negative bacteria, and case fatality rates in the period 1992–2008 were 13–20.6% in patients with CABSI [1]. The overall case fatality of 28% in our CABSI patients was lower than in a study in Thailand [3] from 2004 and 2010 (37.5%) where the most common pathogens were E. coli (23.1%), Burkholderia pseudomallei (19.3%), and S. aureus (8.2%) but higher than in Cambodia (22.1%) where there was a predominance of E. coli (29.7%), Salmonella spp. (14.4%) and B. pseudomallei (12.6%) in the period of 2007–2010) [28]. The higher case fatality in Thailand and our study may relate to the shift in the aetiology of CABSI from Salmonella to other Gram-negative bacteria observed since the last decade.

Organ dysfunction is strongly associated with in-hospital mortality. In a multicentre study of severe sepsis in Spain, case fatality in patients with more than 4 organs with dysfunction was 78.4% [29]. From a large prospective European study, case fatality in patients with more than 3 organs with dysfunction was 58% and the, highest in-hospital mortality rates were observed in patients with coagulation failure (45%) [5]. In high income settings, among ICU patients with suspected infection, the predictive accuracy for in-hospital mortality is higher using SOFA than qSOFA (AUC = 0.74; 95% CI, 0.73–0.76; vs AUC = 0.66; 95% CI, 0.64–0.68) whilst outside of ICU, the predictive validity of qSOFA (AUC = 0.81; 95% CI, 0.80–0.82) was better than SOFA (AUC = 0.79; 95% CI, 0.78–0.80; P < 0.001) [10]. In a prospective study of patients with suspected infection admitted to an emergency department in Norway, the qSOFA had poor performance to predict 7-day and 30-day mortality with AUCs < 0.6 in both multiple imputation and complete case analysis [30]. The usefulness of qSOFA in low- and middle income countries has not been well established. Procalcitonin levels can serve as a useful marker to rule out sepsis and discriminate contamination from true bloodstream infection [31, 32]. Our study shows a poor prediction of initial PCT and CRP in prediction of mortality.

Our study has some major limitations. Firstly, as the study site is a referral hospital specialising in infectious diseases, the aetiologies, clinical manifestations, severity and response to the treatment may be different from those presenting to a general hospital. Secondly, SOFA and qSOFA was calculated based on the worst parameters within 24 h of admission to the study hospital which may not accurately present the severity of infection at arrival. Thirdly, due to the retrospective design, the data collection was incomplete and unbalanced distribution of missing data can be a bias in the prediction models The utilisation of SOFA and qSOFA needs to be validated prospectively in other setting at different time points of assessment.

Conclusions

In conclusion, community acquired BSI has a high rate of organ dysfunction and mortality in this setting. SOFA performed well at predicting those at risk of death admitted directly to CCU, whilst qSOFA performed poorly. Further prospective validation in low- and middle income settings is needed.

Abbreviations

AUC: 

Area under the curve

BSI: 

Bloodstream infection

CABSI: 

Community acquired bloodstream infection

CCU: 

Critical care unit

CI: 

Confidence interval

CNS: 

Central nervous system

CRP: 

C-reactive protein

CSF: 

Cerebral spinal fluid

HR: 

Hazard ratio

ICU: 

Intensive care unit

IQR: 

Interquartile range

LMICs: 

Low- and middle income countries

NHSN: 

National Healthcare Safety Network

NHTD: 

National Hospital for Tropical Diseases

OR: 

Odds ratio

PCT: 

Procalcitonin

qSOFA: 

Quick sequential organ failure assessment

ROC: 

Receiver operating characteristic

SOFA: 

Sequential organ failure assessment

Declarations

Acknowledgments

We gratefully acknowledge the General Planning Department in National Hospital for Tropical Diseases for providing the list of medical records. We also thank Nguyen The Hung, Nguyen Thi Hoa, Bui Linh Chi and Hoang Bao Long for their assistance with data collection.

Funding

This study was funded by the Wellcome Trust of Great Britain.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

VQD designed the study, collected & analysed the data and wrote the first & final draft; NTL, VNH, NDHP collected, entered data, drafted sections of the manuscript; NTL was responsible for cleaning data, analysis and drafted sections of the manuscript; NVT, NVK contributed to study design and were responsible for laboratory and clinical care, provided revisions of the manuscript edited the final draft; HRvD and AB helped with interpretation of the data, revision of the manuscript and edited the final draft; BN involved to design the study, interpreted the data, revised the manuscript and edited the final draft. All authors approved of the final draft.

Ethics approval and consent to participate

The study protocol was reviewed and approved by the ethics committee of the National Hospital of Tropical Diseases in Hanoi, Vietnam (Approval No: 69/HDDD-NDTU). Informed consent was waived due to the retrospective nature of the study. All patient data were anonymised prior to the analysis.

Consent for publication

Not applicable.

Competing interests

HRvD is a member of the editorial board (Associate Editor) of the BMC Infectious Diseases. The authors otherwise declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Infectious Diseases, Hanoi Medical University, no 1 Ton That Tung street, Dong Da district, Hanoi, Vietnam
(2)
Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Hanoi, 78 Giai Phong street, Dong Da district, Hanoi, Vietnam
(3)
National Hospital for Tropical Diseases, 78 Giai Phong street, Dong Da district, Hanoi, Vietnam
(4)
Department of Microbiology, Hanoi Medical University, no 1 Ton That Tung street, Dong Da district, Hanoi, Vietnam
(5)
Nuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, Oxford, UK

References

  1. Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol infect off Publ Eur Soc Clin Microbiol. Infect Dis. 2013;19:501–9.Google Scholar
  2. Kochanek KD, Murphy SL, Xu J, Deaths T-VB. Final data for 2014. Natl vital stat rep cent dis control Prev Natl cent health stat Natl vital stat. Syst. 2016;65:1–122.Google Scholar
  3. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. Epidemiology, Microbiology and mortality associated with community-acquired bacteremia in Northeast Thailand: a multicenter surveillance study. PLoS One. 2013;8:e54714.View ArticleGoogle Scholar
  4. El-Menyar A, Thani HA, Zakaria ER, Zarour A, Tuma M, AbdulRahman H, et al. Multiple organ dysfunction syndrome (MODS): is it preventable or inevitable? Int J Clin Med. 2013;03:722.View ArticleGoogle Scholar
  5. Sakr Y, Lobo SM, Moreno RP, Gerlach H, Ranieri VM, Michalopoulos A, et al. Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit Care Lond Engl. 2012;16:R222.View ArticleGoogle Scholar
  6. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801.View ArticleGoogle Scholar
  7. Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317:290–300.View ArticleGoogle Scholar
  8. Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens Y-E, Avondo A, et al. Prognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA. 2017;317:301–8.View ArticleGoogle Scholar
  9. Churpek MM, Snyder A, Han X, Sokol S, Pettit N, Howell MD, et al. Quick Sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med. 2017;195:906–11.View ArticleGoogle Scholar
  10. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for Sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:762–74.View ArticleGoogle Scholar
  11. Centers for Disease Control and Prevention. NHSN Organism List. 2017. https://www.cdc.gov/nhsn/xls/master-organism-com-commensals-lists.xlsx. Accessed 7 Oct 2017.Google Scholar
  12. Dat VQ, Vu HN. Nguyen the H, Nguyen HT, Hoang LB, vu Tien Viet D, et al. bacterial bloodstream infections in a tertiary infectious diseases hospital in northern Vietnam: aetiology, drug resistance, and treatment outcome. BMC Infect Dis. 2017;17:493.View ArticleGoogle Scholar
  13. World Health Organization. Invasive Bacterial Vaccine Preventable Diseases (IB-VPD) Surveillance Network Case definitions. 2012. http://www.who.int/immunization/monitoring_surveillance/resources/IB-VPD_Case_Defs.pdf. Accessed 7 Oct 2017.Google Scholar
  14. Centers for Disease Control and Prevention. CDC/NHSN Surveillance Definitions for Specific Types of Infections. 2018. https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed 29 Aug 2018.Google Scholar
  15. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34:1913–7.View ArticleGoogle Scholar
  16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.View ArticleGoogle Scholar
  17. Zahar J-R, Timsit J-F, Garrouste-Orgeas M, Français A, Vesin A, Vesim A, et al. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med. 2011;39:1886–95.View ArticleGoogle Scholar
  18. Park HK, Kim WY, Kim MC, Jung W, Ko BS. Quick sequential organ failure assessment compared to systemic inflammatory response syndrome for predicting sepsis in emergency department. J Crit Care. 2017;42:12–7.View ArticleGoogle Scholar
  19. Artero A, Zaragoza R, Camarena JJ, Sancho S, González R, Nogueira JM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care. 2010;25:276–81.View ArticleGoogle Scholar
  20. Peto L, Nadjm B, Horby P, Ngan TTD, van Doorn R, Kinh NV, et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014;108:326–37.View ArticleGoogle Scholar
  21. Huong V, Ha N, Huy N, Peter H, Nghia H, Thiem V, et al. Epidemiology, clinical manifestations, and outcomes of Streptococcus suis infection in humans. Emerg Infect Dis. 2014;20:1105–14.PubMedPubMed CentralGoogle Scholar
  22. Hoa NT, Diep TS, Wain J, Parry CM, Hien TT, Smith MD, et al. Community-acquired septicaemia in southern Viet Nam: the importance of multidrug-resistant Salmonella typhi. Trans R Soc Trop Med Hyg. 1998;92:503–8.View ArticleGoogle Scholar
  23. Mai NTH, Chau TTH, Thwaites G, Chuong LV, Sinh DX, Nghia HDT, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med. 2007;357:2431–40.View ArticleGoogle Scholar
  24. Thornórðardóttir A, Erlendsdóttir H, Sigurðardóttir B, Harðardóttir H, Reynisson IK, Gottfreðsson M, et al. Bacterial meningitis in adults in Iceland, 1995-2010. Scand J Infect Dis. 2014;46:354–60.View ArticleGoogle Scholar
  25. Meyer CN, Samuelsson IS, Galle M, Bangsborg JM. Adult bacterial meningitis: aetiology, penicillin susceptibility, risk factors, prognostic factors and guidelines for empirical antibiotic treatment. Clin Microbiol Infect. 2004;10:709–17.View ArticleGoogle Scholar
  26. Diep NTN, Thai PQ, Trang NNM, Jager J, Fox A, Horby P, et al. Strongyloides stercoralis seroprevalence in Vietnam. Epidemiol Infect. 2017;145(15):3214–8.View ArticleGoogle Scholar
  27. Deen J, von Seidlein L, Andersen F, Elle N, White NJ, Lubell Y. Community-acquired bacterial bloodstream infections in developing countries in south and Southeast Asia: a systematic review. Lancet Infect Dis. 2012;12:480–7.View ArticleGoogle Scholar
  28. Vlieghe ER, Phe T, Smet BD, Veng HC, Kham C, Lim K, et al. Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns. PLoS One. 2013;8:e59775.View ArticleGoogle Scholar
  29. Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008;12:R158.View ArticleGoogle Scholar
  30. Askim Å, Moser F, Gustad LT, Stene H, Gundersen M, Åsvold BO, et al. Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality – a prospective study of patients admitted with infection to the emergency department. Scand J Trauma Resusc Emerg Med. 2017;25:56.View ArticleGoogle Scholar
  31. Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and Sepsis in the emergency department. Am J Clin Pathol. 2011;135:182–9.View ArticleGoogle Scholar
  32. Schuetz P, Mueller B, Trampuz A. Serum Procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection. 2007;35:352.View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement